Rockefeller Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,280
| Closed | -$93K | – | 3248 |
|
|
2022
Q4 | $93K | Sell |
1,280
-7,846
| -86% | -$570K | ﹤0.01% | 2068 |
|
|
2022
Q3 | $693K | Hold |
9,126
| – | – | ﹤0.01% | 1148 |
|
|
2022
Q2 | $634K | Sell |
9,126
-2,590
| -22% | -$180K | ﹤0.01% | 1169 |
|
|
2022
Q1 | $970K | Buy |
11,716
+70
| +0.6% | +$5.8K | ﹤0.01% | 1069 |
|
|
2021
Q4 | $874K | Buy |
11,646
+1,771
| +18% | +$133K | ﹤0.01% | 1099 |
|
|
2021
Q3 | $1.15M | Buy |
9,875
+8,624
| +689% | +$1M | 0.01% | 950 |
|
|
2021
Q2 | $276K | Buy |
1,251
+285
| +30% | +$62.9K | ﹤0.01% | 1394 |
|
|
2021
Q1 | $127K | Sell |
966
-12
| -1% | -$1.58K | ﹤0.01% | 1504 |
|
|
2020
Q4 | $169K | Buy |
978
+690
| +240% | +$119K | ﹤0.01% | 1251 |
|
|
2020
Q3 | $32K | Hold |
288
| – | – | ﹤0.01% | 1639 |
|
|
2020
Q2 | $17K | Hold |
288
| – | – | ﹤0.01% | 1728 |
|
|
2020
Q1 | $19K | Buy |
+288
| New | +$19K | ﹤0.01% | 1536 |
|